RetinalGenix Technologies (RTGN) Total Current Liabilities (2023 - 2026)

RetinalGenix Technologies (RTGN) has 4 years of Total Current Liabilities data on file, last reported at $2.6 million in Q1 2026.

• For the quarter ending Q1 2026, Total Current Liabilities rose 53.02% year-over-year to $2.6 million; the trailing twelve-month figure through Mar 2026 stood at $2.6 million (up 53.02% YoY), and the FY2025 full-year result was $2.3 million, up 57.71% from the prior year.
• Total Current Liabilities improved to $2.6 million in Q1 2026, from $2.3 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $2.6 million in Q1 2026 to a low of $1.4 million in Q4 2023.
• A 4-year average of $1.9 million and a median of $2.0 million in 2024 frame the typical range for Total Current Liabilities.
• Across the five-year window, Total Current Liabilities rose 4.64% in 2024 and jumped 57.71% in 2025, its largest moves.
• Tracing RTGN's Total Current Liabilities over 4 years: stood at $1.4 million in 2023, then grew by 4.64% to $1.5 million in 2024, then jumped by 57.71% to $2.3 million in 2025, then grew by 10.38% to $2.6 million in 2026.
• Business Quant data shows RTGN's Total Current Liabilities at $2.6 million in Q1 2026, $2.3 million in Q4 2025, and $2.2 million in Q3 2025.